NYSE : HTGC

Hercules Capital, Inc.

$15.73 USD

$0.09 (0.58%)

Volume
857.23K
Average Volume
1.57M
Market Capitalization
$2.94B
P/E Ratio
8.60
Dividend Yield
12.40%
Price Target
$16.50
Year High
$19.67
Year Low
$13.70
Day High
Day Low
Payout Ratio
$1.00
Current Ratio
$0.94
Company Overview

NYSE

Scott Bluestein

Asset Management

Financial Services

HTGC

100

US

USD

650 289 3060

427096508

0001280784

Liquidity Metrics

1.15

0.94

0.94

0.94

1.00

Sales & Valuation

$547.1M

5.35

1.29

-8.37

-1.92

Profitability

$1.85

$339.74M

60.28%

60.28%

15.11%

6.88%

P/E Metrics

8.60

0.24

0.24

Analyst Price Target & Rating

$16.50

$17.50

$15.50

Neutral

3/5

31 Analysts

-4.67%

Financial Health Scores

1.05

4/9

-$2.82M

$4.83B

$2.6B

$357.26M

Key Metrics (TTM)

$5.46B

9.91

15.26

0.94

15.11%

7.47%

11.55%

-11.95%

$22.31

-211 days

Company Executives
Name Title
Lake McGuire Managing Director
Greg Peterson Managing Director
John Eggbeer Managing Director
Catherine Jhung Senior Managing Director
Andrew Jordan Olson Chief Financial Officer
R. Bryan Jadot Senior MD & Group Head of Life Sciences
Scott Bluestein CEO, Chief Investment Officer & Director
Seth Hardy Meyer President
Steve Kuo Senior MD & Group Head of Technology
Kate Kinlin Vice President of Human Resources
Kiersten Zaza Botelho Chief Legal Officer, Chief Compliance Officer & Corporate Secretary
Michael W. Hara Managing Director of Investor Relations & Corporation Communications
Christian Follmann Chief Operating Officer
Jasmine Saadati Director of Corporate Development
Lesya Kulchenko Managing Director
Michael Bowden Managing Director of Portfolio Management
Roy Y. Liu Managing Director
Poll Results

No votes yet today — be the first to share your view!

About Hercules Capital, Inc. (NYSE:HTGC) Stock

Hercules Capital, Inc. is a business development company. The firm specializing in providing private equity, venture debt, and growth capital to privately held venture capital-backed companies at all stages of development from mid venture to expansion stage including select publicly listed companies and select special opportunity companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue a ... cceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, SaaS Finance, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels, and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, drug platform, development, and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. Within sustainable and renewables, it invests in Vehicle Technology, Energy Generation and Storage, Ag Technology, Advanced Materials, and Industry 4.0. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest, particularly in the areas of software, biotech, and information services. The firm prefers to invest between $5 million and $500 million in equity per transactions. It invests in debt between $1 million and $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in San Mateo, California with additional offices in North America and Europe.

Blue-Chip 12% Yields: Why I Give Hercules Capital The Edge Over Trinity Capital

2026-07-25 12:00:00

12%-yielding tech lenders Hercules Capital and Trinity Capital now trade at similar 1.3x NAV multiples. I compare them side by side, identifying their pros and cons. I share why I give HTGC the slight edge but also why TRIN might make more sense for some investors.

Hercules Capital Closes Institutional Notes Offering of $325.0 Million 6.300% Unsecured Notes due 2031

2026-07-24 16:05:00

SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), today announced that it has closed an underwritten public offering of $325.0 million in aggregate principal amount of 6.300% notes due July 2031 (the “Notes”). The Notes are unsecured and bear interest at a rate of 6.300% per year, payable semiannually, will mature on July 24, 2031, and may be redeemed in whole or in part at any time or from time to time at the Company's o.

Hercules Capital (HTGC) Falls More Steeply Than Broader Market: What Investors Need to Know

2026-07-22 19:16:06

In the latest trading session, Hercules Capital (HTGC) closed at $15.93, marking a -1.24% move from the previous day.

Hercules Capital Prices Institutional Notes Offering of $325.0 Million 6.300% Notes due 2031

2026-07-21 16:15:00

SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), today announced that it has priced an underwritten public offering of $325.0 million in aggregate principal amount of 6.300% notes due July 2031 (the “Notes”). The closing of the transaction is subject to customary closing conditions and the Notes are expected to be delivered and paid for on July 24, 2026. The Notes are unsecured and bear interest at a rate of 6.300% per y.

Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors

2026-07-16 19:16:14

The latest trading day saw Hercules Capital (HTGC) settling at $16.37, representing a +1.61% change from its previous close.

Hercules Capital Announces Date for Release of Second Quarter 2026 Financial Results and Conference Call

2026-07-16 06:00:00

SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2026 financial results conference call for Thursday, July 30, 2026, at 2:00 p.m. PT (5:00 p.m. ET). Hercules wi.

Hercules Capital (HTGC) Stock Dips While Market Gains: Key Facts

2026-07-09 19:16:13

Hercules Capital (HTGC) reached $15.69 at the closing of the latest trading day, reflecting a -1.26% change compared to its last close.

4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital

2026-06-29 08:00:00

EMERYVILLE, Calif., June 29, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that it has entered into a strategic credit facility agreement with Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”) for up to $200 million.

Frequently Asked Questions

What is the current Hercules Capital, Inc. (HTGC) stock price?

Hercules Capital, Inc.(NYSE:HTGC) stock price is $15.73 in the last trading session. During the trading session, HTGC stock reached the peak price of $19.67 while $13.7 was the lowest point it dropped to. The percentage change in HTGC stock occurred in the recent session was 0.58% while the dollar amount for the price change in HTGC stock was $0.09.

HTGC's industry and sector of operation?

The NYSE listed HTGC is part of Asset Management industry that operates in the broader Financial Services sector.

Who are the executives of HTGC?

Lake McGuire | Managing Director
Greg Peterson | Managing Director
John Eggbeer | Managing Director
Catherine Jhung | Senior Managing Director
Andrew Jordan Olson | Chief Financial Officer

How many employees does HTGC have?

Number of HTGC employees currently stands at 100. HTGC operates from 1 North B Street, San Mateo, CA 94401, US.

Link for HTGC official website?

Official Website of HTGC is: https://www.htgc.com

How do I contact HTGC?

HTGC could be contacted at phone #650 289 3060 and can also be accessed through its website. HTGC operates from 1 North B Street, San Mateo, CA 94401, US.

How many shares of HTGC are traded daily?

The average number of HTGC shares traded daily for last 3 months was 1.57M.

What is the market cap of HTGC currently?

The market value of HTGC currently stands at $2.94B with its latest stock price at $15.73